Tone mix
Week by week 52 weeks
Share of ADMA Biologics, Inc.'s 495 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Dec 8, 2025 · tone +100ADMA Biologics Inc (ADMA) Stock Analysis: Unveiling A Promising 37% Upside Potential+82
- Week of Oct 27, 2025 · tone 0ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025-72
- Week of Aug 25, 2025 · tone +100ADMA Biologics, Inc. (ADMA): A Bull Case Theory+71
- Week of Sep 7, 2026 · tone -87Berger Montague PC Investigates ADMA Biologics, Inc.'s Board of Directors for Breach of Fiduciary Duty (NASDAQ: ADMA)-66
- Week of Apr 13, 2026 · tone -66ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman Investigating-60
- Week of Oct 12, 2026 · tone 0Analyzing Anika Therapeutics (NASDAQ:ANIK) & ADMA Biologics (NASDAQ:ADMA)+45
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about ADMA Biologics, Inc. in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 2 | 0 |
| Last 30 sessions | 5 | 0 |
| Last 90 sessions | 296 | -21 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Friday, October 23, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.tickerreport.com · 1 outletComparing ADMA Biologics (NASDAQ:ADMA) & Rhythm Pharmaceuticals (NASDAQ:RYTM)Neutral
- www.dailypolitical.com · 1 outletContrasting Rhythm Pharmaceuticals (NASDAQ:RYTM) & ADMA Biologics (NASDAQ:ADMA)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Comparing ADMA Biologics (NASDAQ:ADMA) & Rhythm Pharmaceuticals (NASDAQ:RYTM) | www.tickerreport.com | 1 | Neutral |
| Contrasting Rhythm Pharmaceuticals (NASDAQ:RYTM) & ADMA Biologics (NASDAQ:ADMA) | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 19, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletArcturus Therapeutics (NASDAQ:ARCT) & ADMA Biologics (NASDAQ:ADMA) Head-To-Head SurveyNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Arcturus Therapeutics (NASDAQ:ARCT) & ADMA Biologics (NASDAQ:ADMA) Head-To-Head Survey | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 13, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletAnalyzing Anika Therapeutics (NASDAQ:ANIK) & ADMA Biologics (NASDAQ:ADMA)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Analyzing Anika Therapeutics (NASDAQ:ANIK) & ADMA Biologics (NASDAQ:ADMA) | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, September 25, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletFinancial Analysis: Werewolf Therapeutics (NASDAQ:HOWL) versus ADMA Biologics (NASDAQ:ADMA)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Financial Analysis: Werewolf Therapeutics (NASDAQ:HOWL) versus ADMA Biologics (NASDAQ:ADMA) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, September 9, 2026
1 headline, average tone -87: 0 positive, 0 neutral and 1 negative. Showing all 1.
- www.prnewswire.com · 1 outletBerger Montague PC Investigates ADMA Biologics, Inc.'s Board of Directors for Breach of Fiduciary Duty (NASDAQ: ADMA)Negative
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Berger Montague PC Investigates ADMA Biologics, Inc.'s Board of Directors for Breach of Fiduciary Duty (NASDAQ: ADMA) | www.prnewswire.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about ADMA Biologics, Inc., not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.